1. ʻIke laulā
I ke kua o ka hoʻomohala ʻana i nā pono hana lapaʻau, ka hoʻokaʻawale ʻana o nā kumuwaiwai lapaʻau kiʻekiʻe, a me ka hoʻohana nui ʻana i ke ʻoki kino minimally invasive, ke ʻike nei ka endoscope—ma ke ʻano he mea hana koʻikoʻi no ka ʻike ʻana a me ka mālama ʻana i ka maʻi—i kahi loli o ka mākeke. Ke neʻe nei ke koi mai ka "nānā kiʻi" kuʻuna i ka "kiʻi wehewehe kiʻekiʻe" a me ke "kōkua akamai."
Aia ma lalo iho nei kahi loiloi hohonu o ka mākeke endoscope ma Kina no 2025.
Wahi a ka ʻikepili, aia he 14,281 mau hoʻolaha noi lehulehu no nā endoscopes ma Kina i ka makahiki 2025. Ua hōʻea ka nui o ke kūʻai ʻana i 51,121 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 40.822 biliona RMB. Ua uhi kēia mau hana i 3,697 mau hui kūʻai a me 3,968 mau mea lanakila. ʻO ka māhele mākeke e nā lama nui penei: Olympus (33.28%), Karl Storz (16.69%), Fujifilm (14.98%), Sonoscape (10.02%), a me Mindray (8.88%). ʻO ka mea nui, ʻo nā lama ʻekolu kiʻekiʻe loa he 64.95% o ka mākeke.
Kiʻi 1: Ka Māhele Mākeke o nā Lama Endoscope Nui ma Kina e ka Nui o ke Kūʻai Aku, 2025
Kiʻi 2: Nā ʻAno Kūʻai o nā Lama Endoscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai
2. ʻIke Kūʻai Kūʻai ma ke ʻAno Endoscope
ʻO ke Arthroscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 2,399 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 1.752 biliona RMB. ʻO ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Smith & Nephew (28.28%), Richard Wolf (21.23%), CONMED (11.94%), Stryker (11.91%), a me Shenyang Shenda (8.72%). ʻO nā lama ʻekolu kiʻekiʻe loa he 61.44% o ka mākeke.
Kiʻi 3: Nā ʻAno Kūʻai o nā Lama Arthroscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
Gastroscope
ʻO ka nui o ke kūʻai ʻana no nā lako pili he 10,052 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 10.392 biliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Olympus (43.85%), Fujifilm (27.12%), Sonoscape (13.17%), Aohua (10.34%), a me Pentax (4.18%). ʻO nā lama kiʻekiʻe ʻekolu e hui pū ana no 84.14% o ka mākeke.
Kiʻi 4: Nā ʻAno Kūʻai o nā Lama Gastroscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
Bronchoscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 4,696 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 2.717 biliona RMB. ʻO ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Seesheen (25.00%), Olympus (22.13%), Zhejiang UE MEDICAL (12.60%), Insighters (10.04%), a me Fujifilm (8.83%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 59.73% o ka mākeke.
Kiʻi 5: Nā ʻAno Kūʻai o nā Lama Bronchoscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
ʻO ka Laparoscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 11,750 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 13.125 biliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Karl Storz (33.93%), Mindray (22.51%), Kangji Medical (12.72%), Olympus (10.99%), a me OptoMedic (8.68%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 69.16% o ka mākeke.
Kiʻi 6: Nā ʻAno Kūʻai o nā Lama Laparoscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
Hysteroscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 2,672 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 1.14 biliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Hangzhou Suode (26.04%), KMSMED (17.02%), Shenyang Shenda (16.70%), Karl Storz (14.21%), a me Olympus (9.42%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 59.76% o ka mākeke.
Kiʻi 7: Nā ʻAno Kūʻai o nā Lama Hysteroscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
ʻO ke koloscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 922 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 168 miliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Edan (42.51%), ZONSUN (27.57%), TRME (16.00%), Jinyuan Medical (6.72%), a me Leisegang (2.89%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 86.08% o ka mākeke.
Kiʻi 8: Nā ʻAno Kūʻai o nā Lama Colposcope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
Ureteroscope / Nephroscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 2,948 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 496 miliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Hawk Medical (27.11%), Richard Wolf (21.22%), Shenyang Shenda (14.37%), Woek Medical (11.57%), a me Karl Storz (8.80%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 62.70% o ka mākeke.
Kiʻi 9: Nā ʻAno Kūʻai o nā Lama Ureteroscope/Nephroscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
Discope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 664 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 552 miliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: DRAGON CROWN (19.00%), Shenyang Shenda (18.55%), unintech (17.05%), joimax (12.77%), a me CANSUN (11.06%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 54.60% o ka mākeke.
Kiʻi 10: Nā ʻAno Kūʻai o nā Lama Discope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
Koledochoscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 665 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 362 miliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Shanghai Outai (28.22%), Micro-Tech (22.01%), Olympus (21.80%), OptoMedic (15.22%), a me SMOIF (4.32%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 72.03% o ka mākeke.
Kiʻi 11: Nā ʻAno Kūʻai o nā Lama Choledochoscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
ʻO ke kistoscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 1,045 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 184 miliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Hawk Medical (46.32%), Shenyang Shenda (19.19%), Hangzhou Suode (10.51%), Olympus (9.77%), a me Richard Wolf (9.19%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 76.02% o ka mākeke.
Kiʻi 12: Nā ʻAno Kūʻai o nā Lama Cystoscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
ʻO ka Duodenoscope
Ua hōʻea ka nui o ke kūʻai ʻana no nā lako pili i 433 mau ʻāpana/sets/batches, me ka huina kūʻai aku he 350 miliona RMB. Ua puʻunaue ʻia ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Olympus (61.98%), Fujifilm (11.85%), Sonoscape (11.35%), Aohua (8.34%), a me Pentax (3.86%). ʻO nā lama kiʻekiʻe ʻekolu i hui pū ʻia no 85.18% o ka mākeke.
ʻOtorhinolaryngoscope
ʻO ka nui o ke kūʻai ʻana no nā lako pili he 2,566 mau ʻāpana/sets/batches, me ka huina o ka loaʻa kālā kūʻai aku he 1.295 biliona. ʻO ka māhele mākeke ma o ka loaʻa kālā no nā lama nui penei: Olympus (28.27%), Aohua (14.62%), Shenyang Shenda (14.51%), Delong (Fanxing) (13.67%), a me XION (11.20%). ʻO nā lama ʻekolu kiʻekiʻe i hui pū ʻia no kahi māhele mākeke o 57.40%.
Kiʻi 13: Nā ʻAno Kūʻai o nā Lama Otorhinolaryngoscope 5 Kiʻekiʻe ma Kina (2022-2025) ma ka Nui Kūʻai Aku
3. Hoʻohālike Huahana
Hoʻonohonoho Kūlana
Mālama ʻo Olympus i kahi kūlana koʻikoʻi ma nā ʻāpana mākeke āpau. Kū i waho kāna moʻo CV ma ka mākeke, me nā hiʻohiʻona e like me CV-290 a me CV-1500 e hāʻawi ana i ka hana kūʻai aku maikaʻi loa.
Nā Kumu Hoʻohālike o nā Lama Nui
Mālama ʻo Olympus i kahi kūlana koʻikoʻi ma nā ʻāpana mākeke āpau. Kū i waho kāna moʻo CV ma ka mākeke, me nā hiʻohiʻona e like me CV-290 a me CV-1500 e hāʻawi ana i ka hana kūʻai aku maikaʻi loa.
4. Keʻena Kūʻai
Ka Hoʻokaʻawale ʻana o nā ʻĀpana Kūʻai
I ka makahiki 2025, ua helu nā haukapila kula kiʻekiʻe a me nā haukapila kula kiʻekiʻe i 74.35% a me 24.48% o ke kūʻai ʻana, kēlā me kēia.
ʻAno o ka ʻĀpana Kūʻai
Ma ke ʻano o ke ʻano o nā keʻena kūʻai, ʻo nā haukapila laulā a me nā haukapila TCM ka helu no 74.35% a me 24.48% o ke kūʻai ʻana i ka makahiki 2025.
5. Māhele
Ka Hoʻolaha ʻĀpana
I ka makahiki 2025, ʻo ka ʻāina Hikina ka mea i helu i ka hapa nui loa o ka nui o ke kūʻai ʻana ma 43.58%, a ukali ʻia e ka ʻāina Komohana ma 32.55%. Hōʻike ka Kiʻi 16 i ka hoʻolaha ʻana o ke kūʻai ʻana ma nā ʻāpana. Ma ke ʻano o nā panalāʻau, ʻo nā ʻelima kiʻekiʻe ʻo Guangdong, Sichuan, Shandong, Zhejiang, a me Jiangsu.
Nā Lama Kūikawā ma ke Panalāʻau
Ma ke ʻano o nā lama ma kēlā me kēia panalāʻau, ua noho aliʻi ʻia nā panalāʻau ʻelima kiʻekiʻe e Olympus lāua ʻo Karl Storz.
Nā ʻĀpana Kūʻai Nui ma ka Panalāʻau
6. Hōʻuluʻulu Manaʻo
I ka makahiki 2025, ua wehewehe ʻia ka mākeke endoscope o Kina e ʻekolu mau ʻano koʻikoʻi: ka hoʻohui ʻana o ka mākeke ma waena o nā mea pāʻani kiʻekiʻe, ka piʻi ʻana o nā lama kūloko, a me ka decentralization o nā kumuwaiwai.
Ua hōʻea ka huina kūʻai makahiki i 40.82 biliona yuan. Ua hoʻomalu ʻia ka mākeke e ʻekolu mau pilikua nui o nā ʻāina ʻē—ʻo Olympus, Karl Storz, a me Fujifilm—nāna i paʻa i ka 65% o ka māhele mākeke, e mālama ana i kahi monopoly ma nā ʻāpana kiʻekiʻe e like me nā gastroscopes a me nā duodenoscopes. I kēia manawa, ua hoʻokō nā poʻokela kūloko e like me Sonoscape lāua ʻo Mindray i nā holomua ma nā ʻāpana niche e like me nā laparoscopes a me nā colposcopes, e ʻoi aku ana ma mua o nā mea hoʻokūkū haole ma kekahi mau wahi.
Hoʻokele ʻia e ka hoʻoikaika ʻana o nā kulekele ʻōnaehana mālama ola hou a me ka "Thousand County Project," ke wikiwiki nei ka mākeke i nā hoʻonā kiʻekiʻe, akamai, a kūloko. I ka wā e hiki mai ana, e lilo nā ʻenehana e like me ka 4K ultra-high definition, 3D imaging, a me ka AI-assisted diagnosis i mau hiʻohiʻona maʻamau. Ua manaʻo ʻia ma waena o 2026 a me 2027, e ʻoi aku ka nui o ka māhele mākeke o nā lama kūloko ma mua o 35%. Eia kekahi, e hoʻomau ʻia ka hoʻokuʻu ʻia ʻana o ke koi mai nā haukapila ma ka pae kalana a me nā ʻoihana mālama mua, e lawelawe ana ma ke ʻano he ʻenekini ulu hou no ka mākeke.
Manaʻo ʻia e hoʻoikaika nā ʻoihana i ka hana hou ʻenehana, e kālele ana i nā pilikia lapaʻau, a e hoʻolalelale i ka hoʻonui akamai ʻana o nā huahana; pono nā ʻoihana hoʻopukapuka kālā e hoʻolohe i ka puka makani o ka manawa kūpono no ka hoʻololi kūloko a hoʻonohonoho i ke kūkulu ʻana i nā kahawai grassroots; pono nā ʻoihana lapaʻau e loiloi piha i ka hana o nā lako, ke kākoʻo lawelawe a me ke kumukūʻai ola piha, a hoʻokumu ʻepekema i nā hoʻolālā kūʻai.
Ma ZRHmed, ʻaʻole mākou e hana i nā endoscopes. Hana mākou i nā mea hana e hana ai iā lākou -nā hemoclipsno ka hoʻokahe ʻana i ke koko,nā pahele polypectomyno ka wehe ʻana i nā polyp,nā nila sclerotherapyno ka hoʻouna pololei ʻana, endoscopic,nā pulumu hoʻomaʻemaʻeno ka hoʻomaʻemaʻe pono ʻana etc.
ʻOiai e hoʻokūkū ana nā pilikua no nā poʻomanaʻo nui, ke nānā nei mākou i ka mea a mākou e hana maikaʻi loa ai: ka hāʻawi ʻana i nā pono hilinaʻi, CE-marked a me FDA 510 Approval i nā mea hoʻolaha ma ka honua holoʻokoʻa.
No ka mea, ʻoi aku ka nui o nā mea e pono ai kahi kaʻina hana maikaʻi ma mua o kahi laulā nui. Pono ia i nā mea hoʻohui maikaʻi loa.
Ka manawa hoʻouna: ʻApelila-22-2026